ArticlePharmacoepidemiology and drug safety2026
Real-World Data for Safety Studies: Challenges and Opportunities From the Italian Multiple Sclerosis and Related Disorders Register.
Marco Salivetto et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.